What would it take to meaningfully attend to ethnicity and race in health research? Learning from a trial intervention development study.

ethnicity medical sociology race racism randomised controlled trials social inequality

Journal

Sociology of health & illness
ISSN: 1467-9566
Titre abrégé: Sociol Health Illn
Pays: England
ID NLM: 8205036

Informations de publication

Date de publication:
12 2022
Historique:
revised: 12 11 2021
received: 29 01 2021
accepted: 30 11 2021
pubmed: 14 1 2022
medline: 17 12 2022
entrez: 13 1 2022
Statut: ppublish

Résumé

The lack of ethnic diversity in health research participation is a multi-dimensional problem. Racism and intersectional disadvantage compel us to use racial and ethnic categories to explore health, but race theorists warn that these can be essentialising and pathologising. Yet, the alternative, the pursuit of colour-blindness, can render the impact of race and ethnicity on health invisible. This paper describes the attempt to recruit an ethnically diverse sample to inform the development of an intervention for stroke patients. The study revealed deep uncertainties and tensions, which we use to re-examine our own positionalities and perspectives. We focus on the experiences of researchers and participants to show how 'usual' research practices are unwittingly exclusionary and promote 'methodological whiteness' (The British Journal of Sociology, 2017, 68, S214). Calls for greater diversity in research are frequently made, yet health research remains tainted by the use of problematic epistemological starting points, rendering participation by minoritised people uneasy. Medical sociologists, especially those engaged in clinical trials, have a vital role to play in recalibrating health research to attend to ethnicity and race. This requires us to reflect on our practices, to recognise where we are complicit in replicating social inequalities and to actively engage with communities to produce more inclusive research.

Identifiants

pubmed: 35023187
doi: 10.1111/1467-9566.13431
pmc: PMC10078726
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

57-72

Subventions

Organisme : British Heart Foundation
ID : TSA BHF 2017/01
Pays : United Kingdom

Informations de copyright

© 2022 The Authors. Sociology of Health & Illness published by John Wiley & Sons Ltd on behalf of Foundation for SHIL (SHIL).

Références

BMC Med Ethics. 2017 Mar 1;18(1):19
pubmed: 28249596
Health Res Policy Syst. 2020 May 7;18(1):43
pubmed: 32380998
Lancet. 2021 Jan 2;397(10268):17-18
pubmed: 33388099
Sociol Health Illn. 2022 Dec;44 Suppl 1:57-72
pubmed: 35023187
Science. 2016 Feb 5;351(6273):564-5
pubmed: 26912690
Soc Sci Med. 2014 Feb;103:126-133
pubmed: 24507917
Br J Sociol. 2017 Nov;68 Suppl 1:S214-S232
pubmed: 29114873
Health Serv Res. 2019 Dec;54 Suppl 2:1374-1388
pubmed: 31663121
BMC Med Res Methodol. 2021 Apr 21;21(1):80
pubmed: 33882874
Health Soc Care Community. 2004 Sep;12(5):382-8
pubmed: 15373816
Biosocieties. 2021;16(4):470-491
pubmed: 34276806
Health Expect. 2021 Apr;24(2):327-340
pubmed: 33316120
Sociol Health Illn. 2018 Jun;40(5):843-858
pubmed: 29626344
Sociol Health Illn. 2020 Feb;42(2):262-276
pubmed: 31562655
Curr Probl Cardiol. 2019 May;44(5):148-172
pubmed: 30545650
BMJ Glob Health. 2020 Dec;5(12):
pubmed: 33380415
JAMA Cardiol. 2020 Nov 13;:
pubmed: 33185651
BMJ Open. 2012 Nov 05;2(6):
pubmed: 23129572
Sociol Health Illn. 2020 Mar;42(3):610-626
pubmed: 31849069
Soc Sci Med. 2015 Oct;142:128-35
pubmed: 26301485
Am J Public Health. 2006 May;96(5):826-33
pubmed: 16380565
J Health Soc Behav. 1995;Spec No:80-94
pubmed: 7560851
Br J Gen Pract. 2020 Apr 30;70(694):250
pubmed: 32354824
JAMA Oncol. 2019 Jul 1;5(7):975-983
pubmed: 31120534
Qual Health Res. 2019 Apr;29(5):672-679
pubmed: 30791819
Stroke. 2013 Dec;44(12):3298-304
pubmed: 24114452
Am J Public Health. 2010 Apr 1;100 Suppl 1:S30-5
pubmed: 20147679

Auteurs

Tanvi Rai (T)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Lisa Hinton (L)

The Healthcare Improvement Studies Institute, University of Cambridge, Cambridge, UK.

Richard J McManus (RJ)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Catherine Pope (C)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH